Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Shares Repurchased (2012)

Updated

Vistagen Therapeutics' Shares Repurchased was $179,857 in fiscal Q1 2013 (quarter ended Jun 30, 2012).

Analysis

Vistagen Therapeutics (VTGN) Shares Repurchased (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 377.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 1.71 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 5.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 653.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 370.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 179,857.00
API Access

Vistagen Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=VTGN&period=max&api_key=YOUR_API_KEY